BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
FOXP1
,
T cell receptor signaling pathway
,
HIV infection
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fasudil
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
DIDO1
KLF3
PDXK
CHAC1
PES1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
heterocycle metabolic process
cellular aromatic compound metabolic process
organic cyclic compound metabolic process
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lung cancer A549 cells (KRAS mutant) after BI-2536 and fasudil combination treatment
Astrocytes treated with the Rho kinase inhibitor Fasudil
Explore Curated Studies Results
Literature
Most Relevant Literature
Study on development and tissue permeation of different formulations of Fasudil.
Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease.
Antispastic Effect of Fasudil and Cocktail of Fasudil and Nitroglycerin in Internal Thoracic Artery.
The Therapeutic Role of Rho Kinase Inhibitor, Fasudil, on Pulmonary Hypertension; a Systematic Revie…
Therapeutic potentials of fasudil in liver fibrosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fasudil fOr redUcing elopemeNt and Spatial Disorientation
A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (A…
A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial …
Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ